Dr. Cummings is the author of the Neuropsychiatric Inventory (NPI), the most commonly used tool for characterizing behavioural disturbances in dementia syndromes and for measuring the effect of therapies on neuropsychiatric symptoms in Alzheimer’s disease and other dementias.
Dr. Cummings is an experienced clinical trialist with expertise in clinical trial design and analysis, global trial implementation, and trial outcome measures. He has published over 600 articles and 35 books on Alzheimer’s disease and related topics.
Dr. Cummings’ research and leadership in the field of Alzheimer’s disease have been recognized with many awards, including the Henderson Award of the American Geriatrics Society, the Research Award of the John Douglas French Alzheimer’s Research Foundation, and the Ronald and Nancy Reagan Research Award of the national Alzheimer’s Association. In 2010 he was honored by the American Association of Geriatric Psychiatry with their Distinguished Scientist Award.
Journal articles and more to your inbox
Get the latest clinical insights from touchNEUROLOGYSign me up!